Keywords: Roche, Illumina, Raised bid, Amylin, Actavis, Bristol-Myers, Mylan, Watson, M&A speculation

Roche ups bid for Illumina; M&A speculation on Amylin, Actavis

Article | 29 March 2012

Print This

There was a plethora of merger and acquisition news coming out yesterday and this morning, first of which is that ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in